Altogether, our data demonstrate cannabinoid-induced upregulation of ICAM-1 on lung cancer cells to be responsible for increased cancer cell lysis by LAK cells. These findings provide proof for a novel antitumorigenic mechanism of cannabinoids.
Altogether, our data demonstrate cannabinoid-induced upregulation of ICAM-1 on lung cancer cells to be responsible for increased cancer cell lysis by LAK cells. These findings provide proof for a novel antitumorigenic mechanism of cannabinoids.
Contact details
LAYV B.V.
Panamalaan 2G
1019 AZ Amsterdam
📍LAYV CBD
hey@layv.co
Chamber of Commerce: 72846461
VAT: NL859258555B01
Products
© 2023 LAYV B.V.